Flow diagram. by Barbara Mayr (7065950)

“…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…”

Column charts of SI_8min and SI_10min in the therapy and control group at follow-up. by Felix L. Herr (21544362)

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Participants data. by Mohamed Achraf Harrabi (22446782)

“…These improvements could be explained by the increase in hemoglobin (Hb) (by 17.62%) and serum ferritin (by 63.2%) concentrations and the decrease in fatigue scores after the supplementation period.…”

Flow chart of study participants. by Mohamed Achraf Harrabi (22446782)

“…These improvements could be explained by the increase in hemoglobin (Hb) (by 17.62%) and serum ferritin (by 63.2%) concentrations and the decrease in fatigue scores after the supplementation period.…”

General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

Subjects:

Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

Subjects:

Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

Subjects:

Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

Subjects:

Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

Subjects:

Reagent list. by Adrienne J. Bradley (20861948)

“…Dam and pup weights were not altered by Pg-OMV exposure, but pup brain weight was significantly decreased in the Pg-OMV treatment group. …”

Data for figures. by Adrienne J. Bradley (20861948)

“…Dam and pup weights were not altered by Pg-OMV exposure, but pup brain weight was significantly decreased in the Pg-OMV treatment group. …”

In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway. by Leemon Nikhila (22250736)

Changes in the distribution of average sleep duration. by Hea Ree Park (10769827)

Subjects:

Changes in symptoms of insomnia and excessive daytime sleepiness during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Changes in sleep patterns before versus during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Sociodemographic characteristics. by Hea Ree Park (10769827)

Subjects:

Regression analysis of sleep habits and sleep-related symptoms associated with pandemic status. by Hea Ree Park (10769827)

Subjects:

Study flow chart. by Hea Ree Park (10769827)

Subjects:

Spontaneous oxycodone withdrawal disrupts sleep/wake architecture. by Michael Gulledge (20577135)

“…For lights off, there is a significant increase in the # of bouts of all sleep stages (<b>B, C, D, right panels</b>) with a corresponding decrease in Wake bout duration (<b>D, right panel</b>). …”